Group 1 - The company reported total revenue of RMB 1.224 billion and a gross profit of RMB 176 million for the six months ending June 30, 2025, with a gross margin of 14.4% [1] - The normalized net loss was RMB 11.996 million, translating to a loss per share of RMB 0.12 [1] - The company is undergoing a strategic transformation to become a commercial medical payment and healthcare service network, focusing on employee medical security and health management needs [1] Group 2 - The company has made strategic adjustments to enhance its commercial health insurance business, focusing on scaling enterprise health insurance and building service networks [2] - A strategic restructuring of specialty pharmacy and health insurance segments has led to a significant increase in gross margin by 4.7 percentage points to 14.4%, and a substantial reduction in normalized net loss by 59.6% [2] - The company anticipates continued growth in business scale and improvement in profitability, supported by ongoing policy benefits and enhanced service capabilities [2]
思派健康发布中期业绩，整体毛利率同比显著提升4.7个百分点达14.4%